Ignite Creation Date:
2024-05-06 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03526861
Status:
COMPLETED
Last Update Posted:
2023-05-06
First Post:
2018-05-04
Brief Title:
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 ECZema TRAlokinumab Trial no 6
Sponsor:
Organization:
LEO Pharma